superbug
Most Read
Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge
Seagen CEO resigns after arrest on domestic assault charges
One million reasons to reimagine end-of-life care
A ‘city on fire’: How Miami shaped a disputed diagnosis used to justify deaths in police custody
Puzzling pediatric hepatitis cases echo an earlier mysterious illness
When biotech acquisitions spike, early-stage startups are prime targets, analysis shows
FDA approves Lilly diabetes drug that analysts expect to be a big seller
All Coverage
advertisement
